Anti-Human TNFA Recombinant Antibody(Infliximab)
-
产品编号
YR1094
-
别名
科研级 Infliximab ( 英利昔单抗 ), Anti-TNFA Recombinant Antibody, Research Grade Infliximab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1094 |
| Alias | 科研级 Infliximab ( 英利昔单抗 ), Anti-TNFA Recombinant Antibody, Research Grade Infliximab |
| Size | 1mg, 5mg |
| Molecular Name | Infliximab |
| CAS Number | 170277-31-3 |
| Molecular Weight | 149 kDa |
| Target | TNFA[Homo sapiens] |
| Host | Mouse |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. |
| Application | IF, IP, Neut, FuncS, ELISA, FCM, WB |
| Remarks | This product is for research use only. |
0